Low-dose computed tomography and rapid molecular sputum testing in adults with suspected non-ventilator-associated hospital-acquired pneumonia: the HAP-FAST pilot sequential multiple assignment randomised trial with embedded qualitative and costing s
Background Non-ventilator-associated hospital-acquired pneumonia (nv-HAP) diagnosis is imprecise; chest x-rays (CXR) lack detail and sputum culture delays targeted prescribing. However, the evidence base to support diagnostic improvement is sparse. We assessed the feasibility of a trial of low-dose thoracic CT and rapid molecular testing of sputum. Methods HAP-FAST was a UK NIHR funded, open-label pilot sequential multiple assignment randomised trial with qualitative and costing substudies in four UK hospitals (ClinicalTrials.gov: NCT05483309 ). Using research without prior consent (RWPC) and site-stratified web-based randomisation, clinicians allocated adults with suspected nv-HAP (excluding pregnancy and palliation), before their second antibiotic dose, 1:1 to CT or CXR; participants subsequently treated for nv-HAP with sputum available underwent another 1:1 randomisation to BIOFIRE ® FILMARRAY ® Pneumonia plus Panel (FAPP) with standard microbiology or standard microbiology alone . Feasibility outcomes included recruitment, consent, intervention delivery and data completeness through 90 days. Adverse events were not systematically collected. Analyses were intention-to-treat and descriptive. Results Between June 2023 and March 2024, 220 adults were randomised at stage-1 (109 CT; 111 CXR), reaching target three months early. Of 154/220 (70.0%) subsequently managed as nv-HAP, 92/154 (59.7%) could not produce sputum. 62/154 (40.3%; 28.2% of stage-1) were randomised to stage-2: 31 FAPP and 31 no-FAPP. Allocated imaging was recorded for 75/109 (68.8%) CT and 99/111 (89.2%) CXR participants; 6/31(19.4%) FAPP tests were not completed. Consent for follow-up was obtained for 142/220 (64.5%). Protocol-defined clinical cure was assessable in 1/220 participants. The day-90 resource-use questionnaire was returned by 55/110 participants (50.0%). Qualitative findings supported RWPC but identified needs for staged communication, lower-burden follow-up and improved diagnostic pathways. Excess bed days and readmissions drove costs but data capture requires refinement. Conclusions A definitive trial is plausible only with enhanced RWPC, diagnostic delivery and follow-up pathways, improved sputum procedures, stewardship-aligned outcomes and routine economic data capture.
Authors
- Tom Jenks
- Ashley P Jones (ORCID: https://orcid.org/0000-0001-5253-730X)
- Nicola Goddard
- Karl Cook (ORCID: https://orcid.org/0000-0003-1206-8523)
- Dan Gower Wootton (ORCID: https://orcid.org/0000-0002-5903-3881)
- Natalia Shafiqa (ORCID: https://orcid.org/0009-0007-7506-9554)
- Anica Alvarez Nishio (ORCID: https://orcid.org/0000-0001-9841-5682)
- Frances C. Sherratt (ORCID: https://orcid.org/0000-0003-4147-9305)
- Rohit Bazaz (ORCID: https://orcid.org/0000-0002-6078-9272)
- Danielle McLaughlan (ORCID: https://orcid.org/0009-0004-8354-4069)
- Laura Pilling
- C.M. McLeavy (ORCID: https://orcid.org/0000-0001-7043-0266)
- Andrea M. Collins (ORCID: https://orcid.org/0000-0002-4094-1572)
- Karen Irwin
- Helen Clay (ORCID: https://orcid.org/0009-0004-6887-7658)
- Simon Timothy Abrams (ORCID: https://orcid.org/0000-0003-3949-2455)
- Stephen Aston (ORCID: https://orcid.org/0000-0002-0701-8364)
- Bridget Young (ORCID: https://orcid.org/0000-0001-6041-9901)
- Erica Thwaite (ORCID: https://orcid.org/0009-0002-5062-5167)
- Ian Powell (ORCID: https://orcid.org/0009-0002-0975-5613)
- Fred Fyles (ORCID: https://orcid.org/0000-0002-5141-6220)
- Lance C. W. Turtle (ORCID: https://orcid.org/0000-0002-0778-1693)
- James Hare (ORCID: https://orcid.org/0000-0001-8594-3224)
- Stephanie Willshaw (ORCID: https://orcid.org/0009-0001-8630-7497)
- Himanshu Pratap Singh (ORCID: https://orcid.org/0000-0003-1874-0851)
- Joseph Wood (ORCID: https://orcid.org/0000-0002-0483-7110)
- Andy Cross
- Alex Howard (ORCID: https://orcid.org/0000-0002-4195-6821)
- John Howells
- Irene Poku
- Sam Trewick
- Amy Tao (ORCID: https://orcid.org/0009-0000-8073-0705)
- Emily Lam
- Fatima Khalid
- Emini Adegbenro
- Kurian Kalapurakal
- Kerry Edwards
- Becci Pearce
- Patrick Evans
- Anja N Guldemond (ORCID: https://orcid.org/0009-0003-4562-9646)
- Juliette Hucker-Shaw
Institutions
- Lancashire Teaching Hospitals NHS Foundation Trust (GB)
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Royal Liverpool University Hospital (GB)
- National Institute for Health and Care Research (GB)
- Aintree University Hospital (GB)
- Manchester University NHS Foundation Trust (GB)
- Warrington and Halton Teaching Hospitals NHS Foundation Trust (GB)
- Biology of Infection (FR)
- Warrington Hospital (GB)
- Wythenshawe Hospital (GB)
- Royal Preston Hospital (GB)
- Oldham Council (GB)
- Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool (GB)
- Liverpool University Hospitals NHS Foundation Trust (GB)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.10.26367346
- Primary Topic
- Nosocomial Infections in ICU
- Type
- preprint